nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—ADRB2—Timolol—migraine	0.103	0.138	CbGbCtD
Formoterol—ADRB1—Timolol—migraine	0.101	0.136	CbGbCtD
Formoterol—ADRB2—Propranolol—migraine	0.0918	0.123	CbGbCtD
Formoterol—ADRB1—Propranolol—migraine	0.0905	0.121	CbGbCtD
Formoterol—CYP2A6—Valproic Acid—migraine	0.0577	0.0775	CbGbCtD
Formoterol—CYP2C19—Timolol—migraine	0.034	0.0456	CbGbCtD
Formoterol—CYP2C19—Propranolol—migraine	0.0303	0.0407	CbGbCtD
Formoterol—CYP2C19—Amitriptyline—migraine	0.0262	0.0352	CbGbCtD
Formoterol—CYP2D6—Timolol—migraine	0.0258	0.0347	CbGbCtD
Formoterol—CYP2C19—Valproic Acid—migraine	0.0239	0.0321	CbGbCtD
Formoterol—CYP2D6—Propranolol—migraine	0.023	0.0309	CbGbCtD
Formoterol—CYP2C9—Amitriptyline—migraine	0.0218	0.0292	CbGbCtD
Formoterol—CYP2C19—Topiramate—migraine	0.0216	0.0289	CbGbCtD
Formoterol—CYP2C19—Verapamil—migraine	0.0208	0.0279	CbGbCtD
Formoterol—CYP2D6—Amitriptyline—migraine	0.0199	0.0267	CbGbCtD
Formoterol—CYP2C9—Valproic Acid—migraine	0.0199	0.0267	CbGbCtD
Formoterol—CYP2C9—Verapamil—migraine	0.0173	0.0232	CbGbCtD
Formoterol—CYP2D6—Verapamil—migraine	0.0158	0.0212	CbGbCtD
Formoterol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.00196	0.0388	CbGpPWpGaD
Formoterol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.00196	0.0388	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.00142	0.0282	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.00139	0.0276	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.00132	0.0262	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.00129	0.0256	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.00119	0.0237	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.00117	0.0232	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.00111	0.022	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.00109	0.0215	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000861	0.0171	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.000842	0.0167	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000829	0.0164	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000811	0.0161	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000801	0.0159	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000783	0.0155	CbGpPWpGaD
Formoterol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.000779	0.0154	CbGpPWpGaD
Formoterol—ADRB1—Endothelin Pathways—CALCA—migraine	0.00075	0.0149	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000724	0.0144	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000708	0.014	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000701	0.0139	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000697	0.0138	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000686	0.0136	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000682	0.0135	CbGpPWpGaD
Formoterol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000678	0.0134	CbGpPWpGaD
Formoterol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000678	0.0134	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000673	0.0133	CbGpPWpGaD
Formoterol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000664	0.0132	CbGpPWpGaD
Formoterol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000664	0.0132	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000658	0.0131	CbGpPWpGaD
Formoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000612	0.0121	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.000589	0.0117	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000577	0.0114	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000491	0.00974	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.00048	0.00952	CbGpPWpGaD
Formoterol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000444	0.0088	CbGpPWpGaD
Formoterol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000434	0.00861	CbGpPWpGaD
Formoterol—CYP2A6—Fluoropyrimidine Activity—MTHFR—migraine	0.000428	0.00849	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000413	0.00818	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000404	0.00801	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000338	0.00671	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Other—HTR7—migraine	0.000305	0.00604	CbGpPWpGaD
Formoterol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000283	0.00561	CbGpPWpGaD
Formoterol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000277	0.00549	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000274	0.00544	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000268	0.00532	CbGpPWpGaD
Formoterol—ADRB1—G alpha (s) signalling events—CALCA—migraine	0.00026	0.00515	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000255	0.00506	CbGpPWpGaD
Formoterol—Back pain—Valproic Acid—migraine	0.000254	0.00124	CcSEcCtD
Formoterol—ADRB2—G alpha (s) signalling events—CALCA—migraine	0.000254	0.00504	CbGpPWpGaD
Formoterol—Headache—Amitriptyline—migraine	0.000253	0.00124	CcSEcCtD
Formoterol—Bronchitis—Topiramate—migraine	0.000253	0.00124	CcSEcCtD
Formoterol—Muscle spasms—Valproic Acid—migraine	0.000253	0.00124	CcSEcCtD
Formoterol—Rhinitis—Gabapentin—migraine	0.000251	0.00123	CcSEcCtD
Formoterol—Cardiac disorder—Timolol—migraine	0.00025	0.00122	CcSEcCtD
Formoterol—Feeling abnormal—Verapamil—migraine	0.000249	0.00122	CcSEcCtD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000249	0.00495	CbGpPWpGaD
Formoterol—Pharyngitis—Gabapentin—migraine	0.000249	0.00121	CcSEcCtD
Formoterol—Urinary tract disorder—Gabapentin—migraine	0.000247	0.00121	CcSEcCtD
Formoterol—Oedema peripheral—Gabapentin—migraine	0.000247	0.00121	CcSEcCtD
Formoterol—Tremor—Valproic Acid—migraine	0.000246	0.0012	CcSEcCtD
Formoterol—ADRB1—GPCR ligand binding—RAMP1—migraine	0.000246	0.00488	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—CALCRL—migraine	0.000246	0.00488	CbGpPWpGaD
Formoterol—Connective tissue disorder—Gabapentin—migraine	0.000246	0.0012	CcSEcCtD
Formoterol—Urethral disorder—Gabapentin—migraine	0.000246	0.0012	CcSEcCtD
Formoterol—Upper respiratory tract infection—Topiramate—migraine	0.000245	0.0012	CcSEcCtD
Formoterol—Ill-defined disorder—Valproic Acid—migraine	0.000244	0.00119	CcSEcCtD
Formoterol—ADRB1—G alpha (s) signalling events—HTR7—migraine	0.000243	0.00482	CbGpPWpGaD
Formoterol—Immune system disorder—Timolol—migraine	0.000243	0.00119	CcSEcCtD
Formoterol—Hypersensitivity—Propranolol—migraine	0.000242	0.00118	CcSEcCtD
Formoterol—Mediastinal disorder—Timolol—migraine	0.000242	0.00118	CcSEcCtD
Formoterol—Agitation—Valproic Acid—migraine	0.000242	0.00118	CcSEcCtD
Formoterol—Visual impairment—Gabapentin—migraine	0.000241	0.00118	CcSEcCtD
Formoterol—ADRB2—GPCR ligand binding—CALCRL—migraine	0.000241	0.00478	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—RAMP1—migraine	0.000241	0.00478	CbGpPWpGaD
Formoterol—Urticaria—Verapamil—migraine	0.000241	0.00118	CcSEcCtD
Formoterol—Angioedema—Valproic Acid—migraine	0.00024	0.00117	CcSEcCtD
Formoterol—Arrhythmia—Timolol—migraine	0.00024	0.00117	CcSEcCtD
Formoterol—Nausea—Amitriptyline—migraine	0.00024	0.00117	CcSEcCtD
Formoterol—ADRB2—G alpha (s) signalling events—HTR7—migraine	0.000238	0.00472	CbGpPWpGaD
Formoterol—Hyperglycaemia—Topiramate—migraine	0.000237	0.00116	CcSEcCtD
Formoterol—Malaise—Valproic Acid—migraine	0.000237	0.00116	CcSEcCtD
Formoterol—Asthenia—Propranolol—migraine	0.000236	0.00115	CcSEcCtD
Formoterol—Mental disorder—Timolol—migraine	0.000236	0.00115	CcSEcCtD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000235	0.00466	CbGpPWpGaD
Formoterol—Malnutrition—Timolol—migraine	0.000234	0.00114	CcSEcCtD
Formoterol—Cardiac disorder—Gabapentin—migraine	0.000232	0.00114	CcSEcCtD
Formoterol—Palpitations—Valproic Acid—migraine	0.000232	0.00114	CcSEcCtD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00023	0.00456	CbGpPWpGaD
Formoterol—Tension—Timolol—migraine	0.00023	0.00112	CcSEcCtD
Formoterol—Cough—Valproic Acid—migraine	0.00023	0.00112	CcSEcCtD
Formoterol—Dysgeusia—Timolol—migraine	0.000229	0.00112	CcSEcCtD
Formoterol—Urinary tract infection—Topiramate—migraine	0.000228	0.00112	CcSEcCtD
Formoterol—Conjunctivitis—Topiramate—migraine	0.000228	0.00112	CcSEcCtD
Formoterol—Nervousness—Timolol—migraine	0.000227	0.00111	CcSEcCtD
Formoterol—Hypertension—Valproic Acid—migraine	0.000227	0.00111	CcSEcCtD
Formoterol—Immune system disorder—Gabapentin—migraine	0.000226	0.00111	CcSEcCtD
Formoterol—Mediastinal disorder—Gabapentin—migraine	0.000226	0.0011	CcSEcCtD
Formoterol—Diarrhoea—Propranolol—migraine	0.000225	0.0011	CcSEcCtD
Formoterol—Arthralgia—Valproic Acid—migraine	0.000224	0.00109	CcSEcCtD
Formoterol—Myalgia—Valproic Acid—migraine	0.000224	0.00109	CcSEcCtD
Formoterol—Chest pain—Valproic Acid—migraine	0.000224	0.00109	CcSEcCtD
Formoterol—Haematuria—Topiramate—migraine	0.000224	0.00109	CcSEcCtD
Formoterol—Anxiety—Valproic Acid—migraine	0.000223	0.00109	CcSEcCtD
Formoterol—Hypersensitivity—Verapamil—migraine	0.000223	0.00109	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000222	0.00109	CcSEcCtD
Formoterol—Discomfort—Valproic Acid—migraine	0.000221	0.00108	CcSEcCtD
Formoterol—Sinusitis—Topiramate—migraine	0.00022	0.00108	CcSEcCtD
Formoterol—Mental disorder—Gabapentin—migraine	0.000219	0.00107	CcSEcCtD
Formoterol—Dry mouth—Valproic Acid—migraine	0.000219	0.00107	CcSEcCtD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000218	0.00433	CbGpPWpGaD
Formoterol—Malnutrition—Gabapentin—migraine	0.000218	0.00107	CcSEcCtD
Formoterol—Dizziness—Propranolol—migraine	0.000218	0.00106	CcSEcCtD
Formoterol—Asthenia—Verapamil—migraine	0.000217	0.00106	CcSEcCtD
Formoterol—Anaphylactic shock—Valproic Acid—migraine	0.000215	0.00105	CcSEcCtD
Formoterol—Oedema—Valproic Acid—migraine	0.000215	0.00105	CcSEcCtD
Formoterol—Pruritus—Verapamil—migraine	0.000214	0.00105	CcSEcCtD
Formoterol—Tension—Gabapentin—migraine	0.000214	0.00105	CcSEcCtD
Formoterol—Angioedema—Timolol—migraine	0.000214	0.00105	CcSEcCtD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000214	0.00424	CbGpPWpGaD
Formoterol—Dysgeusia—Gabapentin—migraine	0.000214	0.00104	CcSEcCtD
Formoterol—ADRB2—GPCRs, Other—HTR2A—migraine	0.000213	0.00423	CbGpPWpGaD
Formoterol—Infection—Valproic Acid—migraine	0.000213	0.00104	CcSEcCtD
Formoterol—CYP2A6—NRF2 pathway—SLC6A4—migraine	0.000213	0.00422	CbGpPWpGaD
Formoterol—Nervousness—Gabapentin—migraine	0.000212	0.00103	CcSEcCtD
Formoterol—Rhinitis—Topiramate—migraine	0.000211	0.00103	CcSEcCtD
Formoterol—Back pain—Gabapentin—migraine	0.000211	0.00103	CcSEcCtD
Formoterol—Nervous system disorder—Valproic Acid—migraine	0.000211	0.00103	CcSEcCtD
Formoterol—Muscle spasms—Gabapentin—migraine	0.00021	0.00102	CcSEcCtD
Formoterol—Tachycardia—Valproic Acid—migraine	0.000209	0.00102	CcSEcCtD
Formoterol—Vomiting—Propranolol—migraine	0.000209	0.00102	CcSEcCtD
Formoterol—Pharyngitis—Topiramate—migraine	0.000209	0.00102	CcSEcCtD
Formoterol—Skin disorder—Valproic Acid—migraine	0.000208	0.00102	CcSEcCtD
Formoterol—Urinary tract disorder—Topiramate—migraine	0.000208	0.00102	CcSEcCtD
Formoterol—Oedema peripheral—Topiramate—migraine	0.000208	0.00101	CcSEcCtD
Formoterol—Rash—Propranolol—migraine	0.000208	0.00101	CcSEcCtD
Formoterol—Dermatitis—Propranolol—migraine	0.000207	0.00101	CcSEcCtD
Formoterol—Diarrhoea—Verapamil—migraine	0.000207	0.00101	CcSEcCtD
Formoterol—Connective tissue disorder—Topiramate—migraine	0.000207	0.00101	CcSEcCtD
Formoterol—Palpitations—Timolol—migraine	0.000207	0.00101	CcSEcCtD
Formoterol—Urethral disorder—Topiramate—migraine	0.000207	0.00101	CcSEcCtD
Formoterol—Cough—Timolol—migraine	0.000204	0.000998	CcSEcCtD
Formoterol—Tremor—Gabapentin—migraine	0.000204	0.000998	CcSEcCtD
Formoterol—Visual impairment—Topiramate—migraine	0.000203	0.000992	CcSEcCtD
Formoterol—Ill-defined disorder—Gabapentin—migraine	0.000202	0.000989	CcSEcCtD
Formoterol—Hypertension—Timolol—migraine	0.000202	0.000988	CcSEcCtD
Formoterol—Hypotension—Valproic Acid—migraine	0.000201	0.00098	CcSEcCtD
Formoterol—Agitation—Gabapentin—migraine	0.0002	0.000979	CcSEcCtD
Formoterol—Dizziness—Verapamil—migraine	0.0002	0.000978	CcSEcCtD
Formoterol—Myalgia—Timolol—migraine	0.000199	0.000974	CcSEcCtD
Formoterol—Arthralgia—Timolol—migraine	0.000199	0.000974	CcSEcCtD
Formoterol—Chest pain—Timolol—migraine	0.000199	0.000974	CcSEcCtD
Formoterol—Angioedema—Gabapentin—migraine	0.000199	0.000974	CcSEcCtD
Formoterol—Anxiety—Timolol—migraine	0.000199	0.000971	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000198	0.000967	CcSEcCtD
Formoterol—Discomfort—Timolol—migraine	0.000197	0.000962	CcSEcCtD
Formoterol—Malaise—Gabapentin—migraine	0.000197	0.000961	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Valproic Acid—migraine	0.000196	0.000956	CcSEcCtD
Formoterol—Cardiac disorder—Topiramate—migraine	0.000196	0.000956	CcSEcCtD
Formoterol—Nausea—Propranolol—migraine	0.000195	0.000955	CcSEcCtD
Formoterol—Dry mouth—Timolol—migraine	0.000195	0.000953	CcSEcCtD
Formoterol—Insomnia—Valproic Acid—migraine	0.000194	0.000949	CcSEcCtD
Formoterol—Palpitations—Gabapentin—migraine	0.000193	0.000942	CcSEcCtD
Formoterol—Vomiting—Verapamil—migraine	0.000192	0.000941	CcSEcCtD
Formoterol—Dyspnoea—Valproic Acid—migraine	0.000191	0.000935	CcSEcCtD
Formoterol—Oedema—Timolol—migraine	0.000191	0.000934	CcSEcCtD
Formoterol—Anaphylactic shock—Timolol—migraine	0.000191	0.000934	CcSEcCtD
Formoterol—Rash—Verapamil—migraine	0.000191	0.000933	CcSEcCtD
Formoterol—Somnolence—Valproic Acid—migraine	0.000191	0.000933	CcSEcCtD
Formoterol—Dermatitis—Verapamil—migraine	0.000191	0.000932	CcSEcCtD
Formoterol—Immune system disorder—Topiramate—migraine	0.00019	0.00093	CcSEcCtD
Formoterol—Cough—Gabapentin—migraine	0.00019	0.00093	CcSEcCtD
Formoterol—Mediastinal disorder—Topiramate—migraine	0.00019	0.000928	CcSEcCtD
Formoterol—Infection—Timolol—migraine	0.00019	0.000928	CcSEcCtD
Formoterol—Headache—Verapamil—migraine	0.00019	0.000927	CcSEcCtD
Formoterol—Dyspepsia—Valproic Acid—migraine	0.000189	0.000923	CcSEcCtD
Formoterol—Hypertension—Gabapentin—migraine	0.000188	0.00092	CcSEcCtD
Formoterol—Nervous system disorder—Timolol—migraine	0.000187	0.000916	CcSEcCtD
Formoterol—Myalgia—Gabapentin—migraine	0.000186	0.000907	CcSEcCtD
Formoterol—Chest pain—Gabapentin—migraine	0.000186	0.000907	CcSEcCtD
Formoterol—Arthralgia—Gabapentin—migraine	0.000186	0.000907	CcSEcCtD
Formoterol—Skin disorder—Timolol—migraine	0.000186	0.000907	CcSEcCtD
Formoterol—Gastrointestinal disorder—Valproic Acid—migraine	0.000185	0.000906	CcSEcCtD
Formoterol—Fatigue—Valproic Acid—migraine	0.000185	0.000904	CcSEcCtD
Formoterol—Anxiety—Gabapentin—migraine	0.000185	0.000904	CcSEcCtD
Formoterol—Mental disorder—Topiramate—migraine	0.000185	0.000902	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000184	0.000901	CcSEcCtD
Formoterol—Pain—Valproic Acid—migraine	0.000184	0.000897	CcSEcCtD
Formoterol—Constipation—Valproic Acid—migraine	0.000184	0.000897	CcSEcCtD
Formoterol—Malnutrition—Topiramate—migraine	0.000183	0.000896	CcSEcCtD
Formoterol—Discomfort—Gabapentin—migraine	0.000183	0.000896	CcSEcCtD
Formoterol—Dry mouth—Gabapentin—migraine	0.000182	0.000887	CcSEcCtD
Formoterol—Tension—Topiramate—migraine	0.00018	0.00088	CcSEcCtD
Formoterol—Nausea—Verapamil—migraine	0.00018	0.000879	CcSEcCtD
Formoterol—Dysgeusia—Topiramate—migraine	0.00018	0.000878	CcSEcCtD
Formoterol—ADRB1—GPCR ligand binding—HTR1D—migraine	0.000179	0.00355	CbGpPWpGaD
Formoterol—Hypotension—Timolol—migraine	0.000179	0.000873	CcSEcCtD
Formoterol—Nervousness—Topiramate—migraine	0.000178	0.000871	CcSEcCtD
Formoterol—Anaphylactic shock—Gabapentin—migraine	0.000178	0.00087	CcSEcCtD
Formoterol—Oedema—Gabapentin—migraine	0.000178	0.00087	CcSEcCtD
Formoterol—Back pain—Topiramate—migraine	0.000177	0.000867	CcSEcCtD
Formoterol—Feeling abnormal—Valproic Acid—migraine	0.000177	0.000864	CcSEcCtD
Formoterol—Infection—Gabapentin—migraine	0.000177	0.000864	CcSEcCtD
Formoterol—Muscle spasms—Topiramate—migraine	0.000176	0.000862	CcSEcCtD
Formoterol—Gastrointestinal pain—Valproic Acid—migraine	0.000176	0.000858	CcSEcCtD
Formoterol—ADRB2—GPCR ligand binding—HTR1D—migraine	0.000175	0.00347	CbGpPWpGaD
Formoterol—Nervous system disorder—Gabapentin—migraine	0.000175	0.000853	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Timolol—migraine	0.000174	0.000851	CcSEcCtD
Formoterol—Tachycardia—Gabapentin—migraine	0.000174	0.000849	CcSEcCtD
Formoterol—Skin disorder—Gabapentin—migraine	0.000173	0.000845	CcSEcCtD
Formoterol—Insomnia—Timolol—migraine	0.000173	0.000845	CcSEcCtD
Formoterol—Tremor—Topiramate—migraine	0.000172	0.00084	CcSEcCtD
Formoterol—Urticaria—Valproic Acid—migraine	0.000171	0.000833	CcSEcCtD
Formoterol—Dyspnoea—Timolol—migraine	0.00017	0.000833	CcSEcCtD
Formoterol—Ill-defined disorder—Topiramate—migraine	0.00017	0.000832	CcSEcCtD
Formoterol—Somnolence—Timolol—migraine	0.00017	0.00083	CcSEcCtD
Formoterol—Abdominal pain—Valproic Acid—migraine	0.00017	0.000829	CcSEcCtD
Formoterol—Body temperature increased—Valproic Acid—migraine	0.00017	0.000829	CcSEcCtD
Formoterol—Agitation—Topiramate—migraine	0.000169	0.000824	CcSEcCtD
Formoterol—Dyspepsia—Timolol—migraine	0.000168	0.000822	CcSEcCtD
Formoterol—ADRB1—GPCR ligand binding—HTR2B—migraine	0.000166	0.0033	CbGpPWpGaD
Formoterol—Hypotension—Gabapentin—migraine	0.000166	0.000813	CcSEcCtD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000166	0.00329	CbGpPWpGaD
Formoterol—Malaise—Topiramate—migraine	0.000165	0.000808	CcSEcCtD
Formoterol—Gastrointestinal disorder—Timolol—migraine	0.000165	0.000806	CcSEcCtD
Formoterol—Fatigue—Timolol—migraine	0.000165	0.000805	CcSEcCtD
Formoterol—Pain—Timolol—migraine	0.000163	0.000799	CcSEcCtD
Formoterol—ADRB2—GPCR ligand binding—HTR2B—migraine	0.000163	0.00323	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000163	0.00322	CbGpPWpGaD
Formoterol—Musculoskeletal discomfort—Gabapentin—migraine	0.000162	0.000792	CcSEcCtD
Formoterol—Palpitations—Topiramate—migraine	0.000162	0.000792	CcSEcCtD
Formoterol—Insomnia—Gabapentin—migraine	0.000161	0.000787	CcSEcCtD
Formoterol—CYP2A6—NRF2 pathway—TGFBR2—migraine	0.000161	0.00318	CbGpPWpGaD
Formoterol—Cough—Topiramate—migraine	0.00016	0.000782	CcSEcCtD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00016	0.00317	CbGpPWpGaD
Formoterol—Dyspnoea—Gabapentin—migraine	0.000159	0.000775	CcSEcCtD
Formoterol—Hypertension—Topiramate—migraine	0.000158	0.000774	CcSEcCtD
Formoterol—Somnolence—Gabapentin—migraine	0.000158	0.000773	CcSEcCtD
Formoterol—Hypersensitivity—Valproic Acid—migraine	0.000158	0.000773	CcSEcCtD
Formoterol—Feeling abnormal—Timolol—migraine	0.000157	0.00077	CcSEcCtD
Formoterol—Dyspepsia—Gabapentin—migraine	0.000157	0.000765	CcSEcCtD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000156	0.0031	CbGpPWpGaD
Formoterol—Gastrointestinal pain—Timolol—migraine	0.000156	0.000764	CcSEcCtD
Formoterol—Arthralgia—Topiramate—migraine	0.000156	0.000763	CcSEcCtD
Formoterol—Myalgia—Topiramate—migraine	0.000156	0.000763	CcSEcCtD
Formoterol—Chest pain—Topiramate—migraine	0.000156	0.000763	CcSEcCtD
Formoterol—Anxiety—Topiramate—migraine	0.000156	0.000761	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000155	0.000758	CcSEcCtD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000155	0.00306	CbGpPWpGaD
Formoterol—Discomfort—Topiramate—migraine	0.000154	0.000754	CcSEcCtD
Formoterol—Asthenia—Valproic Acid—migraine	0.000154	0.000753	CcSEcCtD
Formoterol—Gastrointestinal disorder—Gabapentin—migraine	0.000154	0.000751	CcSEcCtD
Formoterol—Fatigue—Gabapentin—migraine	0.000153	0.00075	CcSEcCtD
Formoterol—Dry mouth—Topiramate—migraine	0.000153	0.000746	CcSEcCtD
Formoterol—Constipation—Gabapentin—migraine	0.000152	0.000744	CcSEcCtD
Formoterol—Pain—Gabapentin—migraine	0.000152	0.000744	CcSEcCtD
Formoterol—Pruritus—Valproic Acid—migraine	0.000152	0.000742	CcSEcCtD
Formoterol—Urticaria—Timolol—migraine	0.000152	0.000742	CcSEcCtD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000151	0.003	CbGpPWpGaD
Formoterol—Abdominal pain—Timolol—migraine	0.000151	0.000738	CcSEcCtD
Formoterol—Body temperature increased—Timolol—migraine	0.000151	0.000738	CcSEcCtD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00015	0.00298	CbGpPWpGaD
Formoterol—Oedema—Topiramate—migraine	0.00015	0.000732	CcSEcCtD
Formoterol—Infection—Topiramate—migraine	0.000149	0.000727	CcSEcCtD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000147	0.00291	CbGpPWpGaD
Formoterol—Diarrhoea—Valproic Acid—migraine	0.000147	0.000718	CcSEcCtD
Formoterol—Nervous system disorder—Topiramate—migraine	0.000147	0.000717	CcSEcCtD
Formoterol—Feeling abnormal—Gabapentin—migraine	0.000147	0.000717	CcSEcCtD
Formoterol—Tachycardia—Topiramate—migraine	0.000146	0.000714	CcSEcCtD
Formoterol—Gastrointestinal pain—Gabapentin—migraine	0.000146	0.000711	CcSEcCtD
Formoterol—Skin disorder—Topiramate—migraine	0.000145	0.000711	CcSEcCtD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000142	0.00282	CbGpPWpGaD
Formoterol—Dizziness—Valproic Acid—migraine	0.000142	0.000694	CcSEcCtD
Formoterol—Urticaria—Gabapentin—migraine	0.000141	0.000691	CcSEcCtD
Formoterol—Hypersensitivity—Timolol—migraine	0.000141	0.000688	CcSEcCtD
Formoterol—Abdominal pain—Gabapentin—migraine	0.000141	0.000687	CcSEcCtD
Formoterol—Body temperature increased—Gabapentin—migraine	0.000141	0.000687	CcSEcCtD
Formoterol—Hypotension—Topiramate—migraine	0.00014	0.000684	CcSEcCtD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000139	0.00276	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—RAMP1—migraine	0.000139	0.00276	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—CALCRL—migraine	0.000139	0.00276	CbGpPWpGaD
Formoterol—Asthenia—Timolol—migraine	0.000137	0.00067	CcSEcCtD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000137	0.00272	CbGpPWpGaD
Formoterol—Vomiting—Valproic Acid—migraine	0.000136	0.000667	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Topiramate—migraine	0.000136	0.000667	CcSEcCtD
Formoterol—ADRB2—GPCR downstream signaling—CALCRL—migraine	0.000136	0.0027	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—RAMP1—migraine	0.000136	0.0027	CbGpPWpGaD
Formoterol—Insomnia—Topiramate—migraine	0.000135	0.000662	CcSEcCtD
Formoterol—Rash—Valproic Acid—migraine	0.000135	0.000661	CcSEcCtD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000135	0.00268	CbGpPWpGaD
Formoterol—Dermatitis—Valproic Acid—migraine	0.000135	0.000661	CcSEcCtD
Formoterol—Pruritus—Timolol—migraine	0.000135	0.000661	CcSEcCtD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000135	0.00268	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000135	0.00268	CbGpPWpGaD
Formoterol—Headache—Valproic Acid—migraine	0.000134	0.000657	CcSEcCtD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000134	0.00266	CbGpPWpGaD
Formoterol—Dyspnoea—Topiramate—migraine	0.000133	0.000652	CcSEcCtD
Formoterol—Somnolence—Topiramate—migraine	0.000133	0.00065	CcSEcCtD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000132	0.00262	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000132	0.00262	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000132	0.00262	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000132	0.00262	CbGpPWpGaD
Formoterol—Dyspepsia—Topiramate—migraine	0.000132	0.000644	CcSEcCtD
Formoterol—Hypersensitivity—Gabapentin—migraine	0.000131	0.000641	CcSEcCtD
Formoterol—Diarrhoea—Timolol—migraine	0.000131	0.000639	CcSEcCtD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000129	0.00257	CbGpPWpGaD
Formoterol—Gastrointestinal disorder—Topiramate—migraine	0.000129	0.000632	CcSEcCtD
Formoterol—Fatigue—Topiramate—migraine	0.000129	0.000631	CcSEcCtD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000129	0.00255	CbGpPWpGaD
Formoterol—Pain—Topiramate—migraine	0.000128	0.000626	CcSEcCtD
Formoterol—Constipation—Topiramate—migraine	0.000128	0.000626	CcSEcCtD
Formoterol—Asthenia—Gabapentin—migraine	0.000128	0.000624	CcSEcCtD
Formoterol—Nausea—Valproic Acid—migraine	0.000128	0.000623	CcSEcCtD
Formoterol—ADRB1—Signaling by GPCR—CALCRL—migraine	0.000126	0.00251	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—RAMP1—migraine	0.000126	0.00251	CbGpPWpGaD
Formoterol—Dizziness—Timolol—migraine	0.000126	0.000618	CcSEcCtD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000126	0.0025	CbGpPWpGaD
Formoterol—Pruritus—Gabapentin—migraine	0.000126	0.000615	CcSEcCtD
Formoterol—ADRB2—Signaling by GPCR—RAMP1—migraine	0.000124	0.00245	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CALCRL—migraine	0.000124	0.00245	CbGpPWpGaD
Formoterol—Feeling abnormal—Topiramate—migraine	0.000123	0.000603	CcSEcCtD
Formoterol—Gastrointestinal pain—Topiramate—migraine	0.000122	0.000598	CcSEcCtD
Formoterol—Diarrhoea—Gabapentin—migraine	0.000122	0.000595	CcSEcCtD
Formoterol—Vomiting—Timolol—migraine	0.000121	0.000594	CcSEcCtD
Formoterol—Rash—Timolol—migraine	0.00012	0.000589	CcSEcCtD
Formoterol—Dermatitis—Timolol—migraine	0.00012	0.000588	CcSEcCtD
Formoterol—Headache—Timolol—migraine	0.00012	0.000585	CcSEcCtD
Formoterol—Urticaria—Topiramate—migraine	0.000119	0.000581	CcSEcCtD
Formoterol—Body temperature increased—Topiramate—migraine	0.000118	0.000578	CcSEcCtD
Formoterol—Abdominal pain—Topiramate—migraine	0.000118	0.000578	CcSEcCtD
Formoterol—Dizziness—Gabapentin—migraine	0.000118	0.000575	CcSEcCtD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000116	0.0023	CbGpPWpGaD
Formoterol—Nausea—Timolol—migraine	0.000114	0.000555	CcSEcCtD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000113	0.00225	CbGpPWpGaD
Formoterol—Vomiting—Gabapentin—migraine	0.000113	0.000553	CcSEcCtD
Formoterol—Rash—Gabapentin—migraine	0.000112	0.000548	CcSEcCtD
Formoterol—Dermatitis—Gabapentin—migraine	0.000112	0.000548	CcSEcCtD
Formoterol—Headache—Gabapentin—migraine	0.000111	0.000545	CcSEcCtD
Formoterol—Hypersensitivity—Topiramate—migraine	0.00011	0.000539	CcSEcCtD
Formoterol—ADRB1—GPCR ligand binding—HTR1B—migraine	0.000108	0.00215	CbGpPWpGaD
Formoterol—Asthenia—Topiramate—migraine	0.000107	0.000525	CcSEcCtD
Formoterol—ADRB2—GPCR ligand binding—HTR1B—migraine	0.000106	0.0021	CbGpPWpGaD
Formoterol—Pruritus—Topiramate—migraine	0.000106	0.000518	CcSEcCtD
Formoterol—Nausea—Gabapentin—migraine	0.000106	0.000517	CcSEcCtD
Formoterol—ADRB1—GPCR ligand binding—HTR1A—migraine	0.000104	0.00207	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—TAC1—migraine	0.000103	0.00204	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—NPS—migraine	0.000103	0.00204	CbGpPWpGaD
Formoterol—Diarrhoea—Topiramate—migraine	0.000102	0.000501	CcSEcCtD
Formoterol—ADRB2—GPCR ligand binding—HTR1A—migraine	0.000102	0.00202	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR1D—migraine	0.000101	0.002	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—HTR2C—migraine	0.000101	0.002	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—TAC1—migraine	0.000101	0.00199	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—NPS—migraine	0.000101	0.00199	CbGpPWpGaD
Formoterol—Dizziness—Topiramate—migraine	9.9e-05	0.000484	CcSEcCtD
Formoterol—ADRB2—GPCR downstream signaling—HTR1D—migraine	9.89e-05	0.00196	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—HTR2C—migraine	9.86e-05	0.00195	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—EDNRA—migraine	9.81e-05	0.00194	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—EDNRA—migraine	9.59e-05	0.0019	CbGpPWpGaD
Formoterol—Vomiting—Topiramate—migraine	9.52e-05	0.000465	CcSEcCtD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.48e-05	0.00188	CbGpPWpGaD
Formoterol—Rash—Topiramate—migraine	9.44e-05	0.000461	CcSEcCtD
Formoterol—ADRB1—GPCR ligand binding—CALCA—migraine	9.44e-05	0.00187	CbGpPWpGaD
Formoterol—Dermatitis—Topiramate—migraine	9.43e-05	0.000461	CcSEcCtD
Formoterol—ADRB1—GPCR downstream signaling—HTR2B—migraine	9.4e-05	0.00186	CbGpPWpGaD
Formoterol—Headache—Topiramate—migraine	9.38e-05	0.000458	CcSEcCtD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.27e-05	0.00184	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—CALCA—migraine	9.23e-05	0.00183	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR2B—migraine	9.2e-05	0.00182	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR1D—migraine	9.18e-05	0.00182	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR1D—migraine	8.98e-05	0.00178	CbGpPWpGaD
Formoterol—Nausea—Topiramate—migraine	8.89e-05	0.000435	CcSEcCtD
Formoterol—ADRB1—GPCR ligand binding—HTR7—migraine	8.83e-05	0.00175	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—HTR7—migraine	8.64e-05	0.00171	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR2B—migraine	8.54e-05	0.00169	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR2B—migraine	8.35e-05	0.00166	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	8.12e-05	0.00161	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	7.94e-05	0.00157	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RAMP1—migraine	7.47e-05	0.00148	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CALCRL—migraine	7.47e-05	0.00148	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RAMP1—migraine	7.3e-05	0.00145	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CALCRL—migraine	7.3e-05	0.00145	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—HTR2A—migraine	6.18e-05	0.00123	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR1B—migraine	6.13e-05	0.00121	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—HTR2A—migraine	6.05e-05	0.0012	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR1B—migraine	5.99e-05	0.00119	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CACNA1A—migraine	5.91e-05	0.00117	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR1A—migraine	5.9e-05	0.00117	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—NPS—migraine	5.81e-05	0.00115	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—TAC1—migraine	5.81e-05	0.00115	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR1A—migraine	5.77e-05	0.00114	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR2C—migraine	5.7e-05	0.00113	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—TAC1—migraine	5.68e-05	0.00113	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—NPS—migraine	5.68e-05	0.00113	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR2C—migraine	5.57e-05	0.0011	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR1B—migraine	5.56e-05	0.0011	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—EDNRA—migraine	5.54e-05	0.0011	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR1B—migraine	5.44e-05	0.00108	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR1D—migraine	5.43e-05	0.00108	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—EDNRA—migraine	5.42e-05	0.00107	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR1A—migraine	5.36e-05	0.00106	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—CALCA—migraine	5.33e-05	0.00106	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR1D—migraine	5.31e-05	0.00105	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—TAC1—migraine	5.27e-05	0.00105	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—NPS—migraine	5.27e-05	0.00105	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR1A—migraine	5.24e-05	0.00104	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—CALCA—migraine	5.22e-05	0.00103	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR2C—migraine	5.17e-05	0.00103	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—TAC1—migraine	5.16e-05	0.00102	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—NPS—migraine	5.16e-05	0.00102	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR2C—migraine	5.06e-05	0.001	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2B—migraine	5.04e-05	0.001	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EDNRA—migraine	5.03e-05	0.000998	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR7—migraine	4.99e-05	0.000989	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2B—migraine	4.93e-05	0.000978	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EDNRA—migraine	4.92e-05	0.000976	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR7—migraine	4.88e-05	0.000968	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CALCA—migraine	4.84e-05	0.00096	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CALCA—migraine	4.74e-05	0.000939	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR7—migraine	4.53e-05	0.000898	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LRP1—migraine	4.44e-05	0.00088	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR7—migraine	4.43e-05	0.000879	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LRP1—migraine	4.34e-05	0.000861	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CACNA1A—migraine	3.6e-05	0.000715	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR2A—migraine	3.49e-05	0.000693	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR2A—migraine	3.42e-05	0.000678	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOTCH4—migraine	3.41e-05	0.000675	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOTCH4—migraine	3.33e-05	0.000661	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CACNA1A—migraine	3.32e-05	0.000657	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR1B—migraine	3.29e-05	0.000652	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CACNA1A—migraine	3.29e-05	0.000652	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR1B—migraine	3.22e-05	0.000637	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR2A—migraine	3.17e-05	0.000629	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR1A—migraine	3.16e-05	0.000627	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PGR—migraine	3.12e-05	0.000618	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NPS—migraine	3.12e-05	0.000618	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TAC1—migraine	3.12e-05	0.000618	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR2A—migraine	3.1e-05	0.000615	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR1A—migraine	3.1e-05	0.000614	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2C—migraine	3.06e-05	0.000606	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PGR—migraine	3.05e-05	0.000604	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TAC1—migraine	3.05e-05	0.000604	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NPS—migraine	3.05e-05	0.000604	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2C—migraine	2.99e-05	0.000593	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EDNRA—migraine	2.97e-05	0.000589	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EDNRA—migraine	2.91e-05	0.000576	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOTCH3—migraine	2.9e-05	0.000574	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CALCA—migraine	2.86e-05	0.000567	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOTCH3—migraine	2.83e-05	0.000562	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CALCA—migraine	2.8e-05	0.000555	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR7—migraine	2.68e-05	0.000531	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR7—migraine	2.62e-05	0.000519	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TGFBR2—migraine	2.3e-05	0.000457	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TGFBR2—migraine	2.25e-05	0.000447	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MTHFR—migraine	1.96e-05	0.000388	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2A—migraine	1.87e-05	0.000372	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2A—migraine	1.83e-05	0.000364	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ESR1—migraine	1.66e-05	0.00033	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ESR1—migraine	1.63e-05	0.000323	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—migraine	1.19e-05	0.000236	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—migraine	1.1e-05	0.000217	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—migraine	1.09e-05	0.000216	CbGpPWpGaD
